Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzyl benzoate adverse reaction |
Causative agent (attribute) |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Allergy to benzyl benzoate |
Causative agent (attribute) |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
|
Benzyl benzoate 25% application BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
|
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
|
Benzyl penicilloyl-polylysin 0.06mmo injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
|
Product containing benzyl benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
|
Allergy to benzyl benzoate |
Causative agent (attribute) |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing benzyl benzoate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
|
Benzyl benzoate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Benzyl benzoate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Benzyl benzoate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Benzyl benzoate 250 mg/mL cutaneous emulsion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Benzyl benzoate 250 mg/mL cutaneous emulsion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzyl benzoate 225 milligram/1 gram and disulfiram 20 milligram/1 gram conventional release cutaneous emulsion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzyl benzoate 225 milligram/1 gram and disulfiram 20 milligram/1 gram conventional release cutaneous emulsion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
2 |
Product containing only benzyl benzoate and disulfiram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
2 |
Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
2 |
Benzyl benzoate- and disulfiram-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
2 |
Product containing benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Some |
2 |